surmount-1 trial tirzepatide non-diabetic obesity weight loss nondiabetic For the first time, and semaglutide were put in the same trial. SURMOUNT-5. Phase 3b RCT. 751 adults Tirzepatide after intensive lifestyle intervention – Tirzepatide for Obesity Treatment and

When you have three vials in your refrigerator and cannot remember which one you mixed first, you risk using degraded peptide unnecessarily

That changed in 2017, when researchers confirmed the presence of Epitalon in native pineal gland extracts, a discovery that validated its endogenous origin and helped explain its overlap with, but also differences from, Epithalamin [7]

The MHRA approved the Wegovy pill in June 2026, the first weight-loss tablet licensed in the UK, and it reached private providers, including Second Nature, in July 2026

Most users report mild, transient cardiovascular effects during initial use, with some experiencing temporary warmth or flushing from vasodilation

A simple blood test can tell us exactly what your Vitamin B12 levels are

Clinical studies have demonstrated improvements in risk factors including body weight, blood pressure, and certain lipid parameters